Small-fiber-Neuropathien

Weiterbildungsziele

In diesem Beitrag sollen folgende Weiterbildungsziele vermittelt werden:

Kenntnis der klinischen Symptomatik der Small-fiber-Neuropathie Methoden der Diagnostik zur Erfassung der Funktion dünner und unmyelinisierter Fasern Übersicht über die einer Small-fiber-Neuropathie zugrunde liegenden Ätiologien Medikamentöse Therapie der sensorischen und autonomen Symptome im Rahmen einer Schädigung der dünnen Fasern

Literatur

• 1 Ochoa J. Recognition of unmyelinated fiber disease: morphologic criteria.  Muscle Nerve. 1978;  1 375-387
• 2 Weidner C, Schmelz M, Schmidt R. et al . Functional attributes discriminating mechano-insensitive and mechano-responsive C nociceptors in human skin.  J Neurosci. 1999;  19 10184-10190
• 3 Schmelz M, Schmidt R, Bickel A. et al . Specific C-receptors for itch in human skin.  J Neurosci. 1997;  17 8003-8008
• 4 Ali Z, Carroll M, Robertson K P. et al . The extent of small fibre sensory neuropathy in diabetics with plantar foot ulceration.  J Neurol Neurosurg Psychiatry. 1989;  52 94-98
• 5 Burchiel K J. Spontaneous impulse generation in normal and denervated dorsal root ganglia: sensitivity to alpha-adrenergic stimulation and hypoxia.  Exp Neurol. 1984;  85 257-272
• 6 Rolke R, Magerl W, Campbell K A. et al . Quantitative sensory testing: a comprehensive protocol for clinical trials.  Eur J Pain. 2006;  10 77-88
• 7 Ochoa J L, Yarnitsky D. The triple cold syndrome. Cold hyperalgesia, cold hypoaesthesia and cold skin in peripheral nerve disease.  Brain. 1994;  117 185-197
• 8 Schattschneider J, Bode A, Wasner G. et al . Idiopathic restless legs syndrome: abnormalities in central somatosensory processing.  J Neurol. 2004;  251 977-982
• 9 Verdugo R, Ochoa J L. Quantitative somatosensory thermotest. A key method for functional evaluation of small calibre afferent channels.  Brain. 1992;  115 893-913
• 10 Baron R, Saguer M. Postherpetic neuralgia. Are C-nociceptors involved in signalling and maintenance of tactile allodynia?.  Brain. 1993;  116 1477-1496
• 11 Bickel A, Kramer H H, Hilz M J. et al . Assessment of the neurogenic flare reaction in small-fiber neuropathies.  Neurology. 2002;  59 917-919
• 12 Bromm B, Treede R D. Laser evoked cerebral potentials in the diagnosis of cutaneous pain sensitivity.  Rev Neurol. 1991;  147 625-643
• 13 Herrmann D N, Griffin J W, Hauer P. et al . Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies.  Neurology. 1999;  53 1634-1640
• 14 Ziegler D, Laux G, Dannehl K. et al . Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses.  Diabet Med. 1992;  9 166-175
• 15 Baron R, Ewing D J. Heart rate variability. The International Federation of Clinical Neurophysiology.  Electroencephalogr Clin Neurophysiol Suppl. 1999;  52 283-286
• 16 Hilz M J, Dutsch M. Methods of quantitative evaluation of the autonomic nerve system.  Nervenarzt. 2005;  76 767-778; quiz 779 - 780
• 17 The Consensus Committee of the American Autonomic Society and the American Academy of Neurology . Consensus Statement on the definition of orhostatic hypotension, pure autonomic failure and multiple system atrophy.  Neurology. 1996;  46 1470
• 18 Schuller T B, Hermann K, Baron R. Quantitative assessment and correlation of sympathetic, parasympathetic, and afferent small fiber function in peripheral neuropathy.  J Neurol. 2000;  247 267-272
• 19 Riedl B, Nischik M, Birklein F. et al . Spatial extension of sudomotor axon reflex sweating in human skin.  J Auton Nerv Syst. 1998;  69 83-88
• 20 Evans B A, Lussky D, Knezevic W. The peripheral autonomic surface potential in suspected small fiber neuropathy.  Muscle Nerve. 1988;  11 982
• 21 Periquet M I, Novak V, Collins M P. et al . Painful sensory neuropathy: prospective evaluation using skin biopsy.  Neurology. 1999;  53 1641-1647
• 22 Novak V, Freimer M L, Kissel J T. et al . Autonomic impairment in painful neuropathy.  Neurology. 2001;  56 861-868
• 23 Singleton J R, Smith A G, Bromberg M B. Painful sensory polyneuropathy associated with impaired glucose tolerance.  Muscle Nerve. 2001;  24 1225-1228
• 24 McManis P G, Windebank A J, Kiziltan M. Neuropathy associated with hyperlipidemia.  Neurology. 1994;  44 2185-2186
• 25 Koike H, Mori K, Misu K. et al . Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status.  Neurology. 2001;  56 1727-1732
• 26 Schattschneider J, Wasner G, Baron R. Zytostatika induzierte Neuropathien.  Aktuelle Neurologie. 1999;  28 53-61
• 27 Miller R G, Parry G J, Pfaeffl W. et al . The spectrum of peripheral neuropathy associated with ARC and AIDS.  Muscle Nerve. 1988;  11 857-863
• 28 Lacomis D, Giuliani M J, Steen V. et al . Small fiber neuropathy and vasculitis.  Arthritis Rheum. 1997;  40 1173-1177
• 29 Holland N R, Crawford T O, Hauer P. et al . Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases.  Ann Neurol. 1998;  44 47-59
• 30 Mellgren S I, Conn D L, Stevens J C. et al . Peripheral neuropathy in primary Sjogren's syndrome.  Neurology. 1989;  39 390-394
• 31 Orstavik K, Weidner C, Schmidt R. et al . Pathological C-fibres in patients with a chronic painful condition.  Brain. 2003;  126 567-578
• 32 Davies B, Bannester R, Sever P. et al . The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone.  Br J Clin Pharmacol. 1979;  8 253-260
• 33 Jordan J, Shannon J R, Pohar B. et al . Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure.  J Am Soc Nephrol. 1999;  10 35-42
• 34 Jankovic J, Gilden J L, Hiner B C. et al . Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.  Am J Med. 1993;  95 38-48
• 35 Rendell M S, Rajfer J, Wicker P A. et al . Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.  JAMA. 1999;  281 421-426
• 36 Fonseca V, Seftel A, Denne J. et al . Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials.  Diabetologia. 2004;  47 1914-1923
• 37 Finnerup N B, Otto M, McQuay H J. et al . Algorithm for neuropathic pain treatment: an evidence based proposal.  Pain. 2005;  118 289-305
• 38 Rowbotham M C, Goli V, Kunz N R. et al . Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.  Pain. 2004;  110 697-706
• 39 Goldstein D J, Lu Y, Detke M J. et al . Duloxetine vs. placebo in patients with painful diabetic neuropathy.  Pain. 2005;  116 109-118
• 40 Eisenberg E, Lurie Y, Braker C. et al . Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study.  Neurology. 2001;  57 505-509
• 41 Simpson D M, McArthur J C, Olney R. et al . Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial.  Neurology. 2003;  60 1508-1514
• 42 Rowbotham M, Harden N, Stacey B. et al . Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial.  JAMA. 1998;  280 1837-1842
• 43 Backonja M, Beydoun A, Edwards K R. et al . Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.  JAMA. 1998;  280 1831-1836
• 44 Gorson K C, Schott C, Herman R. et al . Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial.  J Neurol Neurosurg Psychiatry. 1999;  66 251-252
• 45 Rice A S, Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study.  Pain. 2001;  94 215-224
• 46 Dworkin R H, Corbin A E, Young J P. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.  Neurology. 2003;  22 1274-1283
• 47 Sabatowski R, Galvez R, Cherry D A. et al . Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.  Pain. 2004;  109 26-35
• 48 Frampton J E, Scott L J. Pregabalin: in the treatment of painful diabetic peripheral neuropathy.  Drugs. 2004;  64 2813-2820
• 49 Lesser H, Sharma U, LaMoreaux L. et al . Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial.  Neurology. 2004;  63 2104-2110
• 50 Frampton J E, Foster R H. Pregabalin: in the treatment of postherpetic neuralgia.  Drugs. 2005;  65 111-118
• 51 Harke H, Gretenkort P, Ladleif H U. et al . The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study.  Anesth Analg. 2001;  92 488-495
• 52 Harati Y, Gooch C, Swenson M. et al . Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy [In Process Citation].  Neurology. 1998;  50 1842-1846
• 53 Sindrup S H, Andersen G, Madsen C. et al . Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.  Pain. 1999;  83 85-90
• 54 Gobel H, Stadler T. Treatment of post-herpes zoster pain with tramadol. Results of an open pilot study versus clomipramine with or without levomepromazine.  Drugs. 1997;  53, Suppl 2 34-39
• 55 Gimbel J S, Richards P, Portenoy R K. Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial.  Neurology. 2003;  60 927-934
• 56 Watson C P, Moulin D, Watt-Watson J. et al . Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.  Pain. 2003;  105 71-78
• 57 Baron R, Maier C. Opioidtherapie neuropathischer Schmerzen.  Akt Neurol. 2000;  27 332-339
• 58 Ziegler D, Hanefeld M, Ruhnau K J. et al . Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study).  Diabetologia. 1995;  38 1425-1433
• 59 Ziegler D, Reljanovic M, Mehnert H. et al . Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.  Exp Clin Endocrinol Diabetes. 1999;  107 421-430
• 60 Ziegler D, Hanefeld M, Ruhnau K J. et al . Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy.  Diabetes Care. 1999;  22 1296-1301
• 61 Ametov A S, Barinov A, Dyck P J. et al . The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.  Diabetes Care. 2003;  26 770-776
• 62 Ziegler D, Nowak H, Kempler P. et al . Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis.  Diabet Med. 2004;  21 114-121